Category: ScienceNews

This week the UK parliament voted to accept the Government’s continued cap on Official Development Aid. This disappointed many researchers around the world, funded directly and indirectly through various scientific funding structures enabling international collaboration on some of the global challenges facing all of us. These funding mechanisms make for a small fraction of the overall amount, but they have been hit hard, with many projects closing altogether.

There had been hope amongst the scientific community that the cap – from 0.7% down to 0.5% of the UK’s Gross Domestic Income – might have been in place just for a year. But it seems like the criteria set to judge when the level of aid might rise again imply that it is unlikely to happen for several years at the earliest.

What, asks Science in Action, does that mean to the world of scientific collaboration on such topics as climate change, contagious disease, and emergency planning?

Researchers Chris Trisos and Jenni Barclay, with journalist Robin Bisson of Research Professional News, update us on the story.

In Zambia, where covid testing remains scarce, a project run by Boston University’s Christopher Gill has been estimating the prevalence of covid in the capital Lusaka by taking nasal swab samples from the noses of around one in five of those recently deceased, in the morgue of a major hospital. Tantalisingly, his team have seen over the last few months a sharp rise in cases to the extent that in June, nearly 90 percent of the cadavers tested positive for covid. But as Chris describes, unrelated to the UK cuts, their funding has now run out, so where the graph leads from here we may not learn for a long time.

Presented by Roland Pease Produced by Alex Mansfield.

(Image: Getty Images)

Delta is quickly becoming the dominant coronavirus variant in multiple countries. The variant has spread so fast because it is more contagious than the variants that came before it. At the same time, the U.S. is equipped with highly effective vaccines. Ed Yong, science writer for The Atlantic, talks with Maddie about the interaction between the variants and the vaccines and how that will be crucial in the months ahead.

Reach the show by emailing shortwave@npr.org.

Learn more about sponsor message choices: podcastchoices.com/adchoices

NPR Privacy Policy

Contrary to sci-fi depictions in shows like Iron Man and Star Wars, getting from point A to point B in space is a tough engineering problem. NPR Science Correspondent Geoff Brumfiel explains how space propulsion actually works, and why some new technologies might be needed to get humans to Mars and beyond.

Follow Geoff Brumfiel and Short Wave co-host Emily Kwong on Twitter. Email the show at shortwave@npr.org.

Learn more about sponsor message choices: podcastchoices.com/adchoices

NPR Privacy Policy

At the height of the pandemic, routine cancer screenings declined by 90 percent. Screenings are resuming and doctors are diagnosing later-stage cancers — cancers that might have been caught earlier. NPR science correspondent Yuki Noguchi of talks about whom this affects most, and about the ripple effects that missing cancer screening may have for years to come.

Learn more about sponsor message choices: podcastchoices.com/adchoices

NPR Privacy Policy

On the mountaintop glaciers of the Pacific Northwest lives a mysterious, and often, overlooked creature. They're small, thread-like worms that wiggle through snow and ice. That's right, ice worms! NPR science correspondent Nell Greenfieldboyce talks to Emily about how they survive in an extreme environment and why scientists don't understand some of the most basic facts about them.

For more of Nell's reporting, you can follow her on Twitter @nell_sci_NPR. You can follow Emily @emilykwong1234.

Email the show with suggestions or thoughts at ShortWave@NPR.org.

Learn more about sponsor message choices: podcastchoices.com/adchoices

NPR Privacy Policy

Standing takes less energy than walking, so why does it feel more tiring? At least, it does for CrowdScience listener Nina. She can march for hours without getting tired, but her legs and feet get achy after just a short time standing still.

It’s one of three walking-themed questions CrowdScience is tackling this week. Taking inspiration from our active listeners, Marnie Chesterton walks up a hill with Caroline Williams, author of a new book about why humans are designed to move. We find out how our whole system – body and brain – works better when we’re walking, compared to standing still. We’re probably set up this way because of our evolutionary history: hunting and gathering needed us to be ‘cognitively engaged endurance athletes’.

We stop for a break.. but is it true that we shouldn’t sit down to rest during a walk? Our listener Sarah is a keen hillwalker but likes to take the weight off her feet every now and again. Her hillwalking friends disapprove, saying she should rest on her feet. Is this a myth CrowdScience can bust?

And finally a question from listener Matteo: is walking or running better for your health? Numerous studies show significant benefits to both forms of exercise, but in the end, the best kind of exercise is the one you’re motivated to do.

With Caroline Williams, Dr François-Xavier Li, Professor Dick Greene and Professor Duck-Chul Lee.

Summer's here. Time for a cool treat. So, you grab a popsicle from the freezer. Ahh ... that's better. Until, out of nowhere, a sharp sudden pain rushes to your forehead. You've got brain freeze!

We talk with neuroscientist Caroline Palavicino-Maggio about the science behind these short-lived cold-induced headaches. Plus, some listener mail.

What are your daily science curiosities? Email the show at shortwave@npr.org.

Learn more about sponsor message choices: podcastchoices.com/adchoices

NPR Privacy Policy

Scientists say the record-breaking Pacific North-West heatwave of recent weeks must have been caused by human induced climate change, but as Geert Jan van Oldenborgh explains to Roland Pease, despite a herculean effort to analyse the event in just a week, the precise mechanism to cause such an extreme and sudden event is so far bewildering climate modellers, exceeding even worst expectations.

Looking to the skies, Rosita Kokotanekova of the European Southern Observatory and colleagues have been getting excited about the discovery of a comet maybe twice as large as any observed before. Being so big, it has been spotted much further out from the sun and – if the best telescopes can be convinced to join the fun – will provide astronomers a chance to observe the core of the comet before the solar heat induces a gaseous coma to form as it nears the point in its orbit closest to the sun. It will be around for the next decade before continuing its several million year journey around our mutual star.

But it won’t get terribly close to earth, at least not as close as lumps of an asteroid that fell onto a driveway in the UK earlier this year. Dr Ashley King of the UK’s Natural History Museum is leading a consortium of scientists (benefitting from a rapid research grant by the UK’s STFC) who have now officially classified it and named it. The Winchcombe meteorite is a CM carbonaceous chondrite, meaning it represents the unspoilt early building blocks of the solar system. Falling like 4.5 billion year old leftover celestial lego, only a few are known around the world but perhaps none have been in scientists hands in such a short period of time, continuing its pristine survival.

Dr Pablo Tsukayama has published a preprint paper announcing a new variant of interest in the ongoing evolution of the SARS-CoV2 virus. Now named by the WHO as the Lambda variant, it seems it has driven the pandemic for much of this year in Peru – as much as 80% of cases – and large fractions of the outbreak elsewhere in South America. But as Pablo suggests, the reason we don’t know as much about it as for example the Alpha or Delta variants is likely because it hasn’t thus far affected the countries best equipped to do the analysis. Maybe that could change.

Image: Wildfires in Lytton, British Columbia Credit: ProPics Canada Media Ltd/Getty Images

Presenter: Roland Pease Producer: Alex Mansfield

FEMA acknowledges that the way it distributes aid often benefits some people more than others--and those who receive less aid are those people with the fewest resources to begin with. Rhitu Chatterjee talks with NPR climate correspondent Rebecca Hersher about her investigation into FEMA and why the federal government's response to disasters may disproportionately hurt people of color and their communities.

Read more of Rebecca's reporting in "Why FEMA Aid Is Unavailable To Many Who Need It The Most."

You can email Short Wave at ShortWave@NPR.org.

Learn more about sponsor message choices: podcastchoices.com/adchoices

NPR Privacy Policy

People between the ages of 12 and 17 are now eligible to get the Pfizer COVID-19 vaccine and health officials expect this age group will soon be able to receive the Moderna one. So, health reporter Pien Huang and Short Wave producer Rebecca Ramirez talked to teens about their questions about the vaccine and what a strange year the pandemic has been for them.

Do you have questions about the coronavirus and the pandemic? Email shortwave@npr.org.

Learn more about sponsor message choices: podcastchoices.com/adchoices

NPR Privacy Policy